首页 > 最新文献

Circulation: Heart Failure最新文献

英文 中文
Stop Dreaming: Mavacamten REMS Data Are Here. 别做梦了Mavacamten REMS 数据来了。
IF 7.8 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-01-01 Epub Date: 2024-11-11 DOI: 10.1161/CIRCHEARTFAILURE.124.012545
Ahmad Masri, Neal K Lakdawala
{"title":"Stop Dreaming: Mavacamten REMS Data Are Here.","authors":"Ahmad Masri, Neal K Lakdawala","doi":"10.1161/CIRCHEARTFAILURE.124.012545","DOIUrl":"10.1161/CIRCHEARTFAILURE.124.012545","url":null,"abstract":"","PeriodicalId":10196,"journal":{"name":"Circulation: Heart Failure","volume":" ","pages":"e012545"},"PeriodicalIF":7.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142615726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is It Primetime for Finerenone in Heart Failure? 芬内酮是治疗心力衰竭的黄金时机吗?
IF 7.8 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-01-01 Epub Date: 2024-11-29 DOI: 10.1161/CIRCHEARTFAILURE.124.012530
Neal M Dixit, Saul Schaefer
{"title":"Is It Primetime for Finerenone in Heart Failure?","authors":"Neal M Dixit, Saul Schaefer","doi":"10.1161/CIRCHEARTFAILURE.124.012530","DOIUrl":"10.1161/CIRCHEARTFAILURE.124.012530","url":null,"abstract":"","PeriodicalId":10196,"journal":{"name":"Circulation: Heart Failure","volume":" ","pages":"e012530"},"PeriodicalIF":7.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142750103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real-Time Pressure-Volume Loop Assessment of Left Ventricular Performance to Evaluate Suitability for Repair in Congenitally Corrected Transposition of the Great Arteries. 实时压力-容积环路评估先天性大动脉转位左心室功能的修复适宜性。
IF 7.8 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-12-27 DOI: 10.1161/CIRCHEARTFAILURE.124.012609
Kyong-Jin Lee, Kaitlin Flannery, Michael Ma, Deborah Ho
{"title":"Real-Time Pressure-Volume Loop Assessment of Left Ventricular Performance to Evaluate Suitability for Repair in Congenitally Corrected Transposition of the Great Arteries.","authors":"Kyong-Jin Lee, Kaitlin Flannery, Michael Ma, Deborah Ho","doi":"10.1161/CIRCHEARTFAILURE.124.012609","DOIUrl":"https://doi.org/10.1161/CIRCHEARTFAILURE.124.012609","url":null,"abstract":"","PeriodicalId":10196,"journal":{"name":"Circulation: Heart Failure","volume":" ","pages":"e012609"},"PeriodicalIF":7.8,"publicationDate":"2024-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142892540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neurohormonal and Renal Effects of 14-Day Oral Ketone Ester Treatment in Patients With Heart Failure With Reduced Ejection Fraction. 口服酮酯治疗心力衰竭伴射血分数降低患者14天的神经激素和肾脏影响。
IF 7.8 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-12-24 DOI: 10.1161/CIRCHEARTFAILURE.124.012167
Kristoffer Berg-Hansen, Nigopan Gopalasingam, Kristian Hylleberg Christensen, Mads Svart, Nikolaj Rittig, Roni Nielsen, Kent Lodberg, Niels Møller, Henrik Wiggers
{"title":"Neurohormonal and Renal Effects of 14-Day Oral Ketone Ester Treatment in Patients With Heart Failure With Reduced Ejection Fraction.","authors":"Kristoffer Berg-Hansen, Nigopan Gopalasingam, Kristian Hylleberg Christensen, Mads Svart, Nikolaj Rittig, Roni Nielsen, Kent Lodberg, Niels Møller, Henrik Wiggers","doi":"10.1161/CIRCHEARTFAILURE.124.012167","DOIUrl":"https://doi.org/10.1161/CIRCHEARTFAILURE.124.012167","url":null,"abstract":"","PeriodicalId":10196,"journal":{"name":"Circulation: Heart Failure","volume":" ","pages":"e012167"},"PeriodicalIF":7.8,"publicationDate":"2024-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142881376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aerobic Capacity of Adults With Fontan Palliation: Disease-Specific Reference Values and Relationship to Outcomes. Fontan姑息治疗成人的有氧能力:疾病特异性参考值及其与预后的关系
IF 7.8 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-12-09 DOI: 10.1161/CIRCHEARTFAILURE.124.011981
Alexander C Egbe, Ahmed E Ali, William R Miranda, Heidi M Connolly, Barry A Borlaug

Background: Patients with Fontan palliation have reduced aerobic capacity because of impaired cardiac, pulmonary, and skeletal muscle function. However, the assessment of aerobic capacity in this population still relies on comparisons with people without cardiovascular disease rather than comparison with the expected aerobic capacity of other Fontan patients. The purpose of this study was to determine the expected aerobic capacity of adults with Fontan palliation.

Methods: Adults with Fontan palliation who underwent a cardiopulmonary exercise test at Mayo Clinic (2003-2023) were stratified into quartiles based on the predicted peak oxygen consumption (VO2). We assessed the correlates of predicted peak VO2 and the relationship between predicted peak VO2 quartiles and cardiovascular outcomes (death/transplant).

Results: Of 323 patients (age, 29±9 years; 177 [55%] men), the median peak VO2 was 19.1 (15.2-23.9) mL/kg per minute, and this corresponds to a predicted peak VO2 of 51% (range, 19-88; interquartile range, 41-62). After multivariable adjustments, the correlates of predicted peak VO2 were body mass index (β±SE, -2.61±0.95; 2.61% decrease in predicted peak VO2 per 5 kg/m2 increase in body mass index; P=0.009), systemic saturation (β±SE, 3.65±0.85; 3.65% increase in predicted peak VO2 per 5% increase in oxygen saturation; P<0.001), and Fontan pressure (β±SE, -1.24±0.22; 1.24% decrease in predicted peak VO2 per 1 mm Hg increase in Fontan pressures; P<0.001). There was a 47% increase in the risk for death/transplant from a higher predicted peak VO2 quartile to the next lower quartile (adjusted hazard ratio, 1.47 [95% CI, 1.09-2.05]; P=0.01).

Conclusions: The results of the current study would help calibrate the interpretation of exercise test data in adults with Fontan palliation and improve risk stratification in this population. It also underscores the need to maintain normal Fontan hemodynamics and body weight, which are important determinants of aerobic capacity.

背景:由于心脏、肺和骨骼肌功能受损,接受Fontan姑息治疗的患者有氧能力降低。然而,该人群的有氧能力评估仍然依赖于与无心血管疾病的人进行比较,而不是与其他Fontan患者的预期有氧能力进行比较。本研究的目的是确定Fontan姑息治疗成人的预期有氧能力。方法:根据预测的峰值耗氧量(VO2),将2003-2023年在梅奥诊所接受心肺运动试验的Fontan缓和患者分为四分位数。我们评估了预测峰值VO2的相关性以及预测峰值VO2四分位数与心血管结局(死亡/移植)之间的关系。结果:323例患者(年龄29±9岁;177[55%]男性),VO2峰值中位数为19.1 (15.2-23.9)mL/kg / min,这对应于预测VO2峰值为51%(范围,19-88;四分位数范围,41-62)。多变量调整后,预测VO2峰值的相关因素为体重指数(β±SE, -2.61±0.95;体重指数每增加5 kg/m2,预测VO2峰值降低2.61%;P=0.009),全身饱和度(β±SE, 3.65±0.85;氧饱和度每增加5%,预测峰值VO2增加3.65%;每增加1毫米汞柱丰滩压力P2;P2四分位数到下一个低四分位数(校正风险比,1.47 [95% CI, 1.09-2.05];P = 0.01)。结论:当前研究的结果将有助于校准对Fontan姑息治疗成人运动试验数据的解释,并改善该人群的风险分层。它还强调需要维持正常的Fontan血流动力学和体重,这是有氧能力的重要决定因素。
{"title":"Aerobic Capacity of Adults With Fontan Palliation: Disease-Specific Reference Values and Relationship to Outcomes.","authors":"Alexander C Egbe, Ahmed E Ali, William R Miranda, Heidi M Connolly, Barry A Borlaug","doi":"10.1161/CIRCHEARTFAILURE.124.011981","DOIUrl":"https://doi.org/10.1161/CIRCHEARTFAILURE.124.011981","url":null,"abstract":"<p><strong>Background: </strong>Patients with Fontan palliation have reduced aerobic capacity because of impaired cardiac, pulmonary, and skeletal muscle function. However, the assessment of aerobic capacity in this population still relies on comparisons with people without cardiovascular disease rather than comparison with the expected aerobic capacity of other Fontan patients. The purpose of this study was to determine the expected aerobic capacity of adults with Fontan palliation.</p><p><strong>Methods: </strong>Adults with Fontan palliation who underwent a cardiopulmonary exercise test at Mayo Clinic (2003-2023) were stratified into quartiles based on the predicted peak oxygen consumption (VO<sub>2</sub>). We assessed the correlates of predicted peak VO<sub>2</sub> and the relationship between predicted peak VO<sub>2</sub> quartiles and cardiovascular outcomes (death/transplant).</p><p><strong>Results: </strong>Of 323 patients (age, 29±9 years; 177 [55%] men), the median peak VO<sub>2</sub> was 19.1 (15.2-23.9) mL/kg per minute, and this corresponds to a predicted peak VO<sub>2</sub> of 51% (range, 19-88; interquartile range, 41-62). After multivariable adjustments, the correlates of predicted peak VO<sub>2</sub> were body mass index (β±SE, -2.61±0.95; 2.61% decrease in predicted peak VO<sub>2</sub> per 5 kg/m<sup>2</sup> increase in body mass index; <i>P</i>=0.009), systemic saturation (β±SE, 3.65±0.85; 3.65% increase in predicted peak VO<sub>2</sub> per 5% increase in oxygen saturation; <i>P</i><0.001), and Fontan pressure (β±SE, -1.24±0.22; 1.24% decrease in predicted peak VO<sub>2</sub> per 1 mm Hg increase in Fontan pressures; <i>P</i><0.001). There was a 47% increase in the risk for death/transplant from a higher predicted peak VO<sub>2</sub> quartile to the next lower quartile (adjusted hazard ratio, 1.47 [95% CI, 1.09-2.05]; <i>P</i>=0.01).</p><p><strong>Conclusions: </strong>The results of the current study would help calibrate the interpretation of exercise test data in adults with Fontan palliation and improve risk stratification in this population. It also underscores the need to maintain normal Fontan hemodynamics and body weight, which are important determinants of aerobic capacity.</p>","PeriodicalId":10196,"journal":{"name":"Circulation: Heart Failure","volume":" ","pages":"e011981"},"PeriodicalIF":7.8,"publicationDate":"2024-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142794252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Insights From a 20-Year Follow-Up of the First Heart Transplant Recipient to Complete an Ironman Triathlon. 对第一个完成铁人三项的心脏移植接受者的20年随访观察。
IF 7.8 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-12-09 DOI: 10.1161/CIRCHEARTFAILURE.124.012027
Stephen J Foulkes, Rachel J Skow, Andre La Gerche, Wayne J Tymchak, Mark J Haykowsky
{"title":"Insights From a 20-Year Follow-Up of the First Heart Transplant Recipient to Complete an Ironman Triathlon.","authors":"Stephen J Foulkes, Rachel J Skow, Andre La Gerche, Wayne J Tymchak, Mark J Haykowsky","doi":"10.1161/CIRCHEARTFAILURE.124.012027","DOIUrl":"https://doi.org/10.1161/CIRCHEARTFAILURE.124.012027","url":null,"abstract":"","PeriodicalId":10196,"journal":{"name":"Circulation: Heart Failure","volume":" ","pages":"e012027"},"PeriodicalIF":7.8,"publicationDate":"2024-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142794269","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cognitive and Procedural Competencies in the Cardiac Intensive Care Unit. 心脏重症监护病房的认知和程序能力。
IF 7.8 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-12-09 DOI: 10.1161/CIRCHEARTFAILURE.124.011641
Willard N Applefeld, Jacob C Jentzer, Saraschandra Vallabhajosyula
{"title":"Cognitive and Procedural Competencies in the Cardiac Intensive Care Unit.","authors":"Willard N Applefeld, Jacob C Jentzer, Saraschandra Vallabhajosyula","doi":"10.1161/CIRCHEARTFAILURE.124.011641","DOIUrl":"https://doi.org/10.1161/CIRCHEARTFAILURE.124.011641","url":null,"abstract":"","PeriodicalId":10196,"journal":{"name":"Circulation: Heart Failure","volume":" ","pages":"e011641"},"PeriodicalIF":7.8,"publicationDate":"2024-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142794257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Socioeconomic Disparities Are Associated With Delayed Access to Tafamidis in Transthyretin Cardiac Amyloidosis. 转甲状腺素性心脏淀粉样变性患者迟迟无法获得他法米迪治疗与社会经济差异有关。
IF 7.8 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-12-01 Epub Date: 2024-11-07 DOI: 10.1161/CIRCHEARTFAILURE.124.012075
Peter Miller, Pierre Elias, Andrew J Einstein, Mathew S Maurer, Gasmelseed Y Ahmed, Timothy J Poterucha
{"title":"Socioeconomic Disparities Are Associated With Delayed Access to Tafamidis in Transthyretin Cardiac Amyloidosis.","authors":"Peter Miller, Pierre Elias, Andrew J Einstein, Mathew S Maurer, Gasmelseed Y Ahmed, Timothy J Poterucha","doi":"10.1161/CIRCHEARTFAILURE.124.012075","DOIUrl":"10.1161/CIRCHEARTFAILURE.124.012075","url":null,"abstract":"","PeriodicalId":10196,"journal":{"name":"Circulation: Heart Failure","volume":" ","pages":"e012075"},"PeriodicalIF":7.8,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11652229/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142590189","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inhibitors of the Interleukin-1 Receptor Accessory Protein Signaling: Another Asset in the Cardio-Immunology Toolbox. 白细胞介素-1 受体附属蛋白信号抑制剂:心脏病免疫学工具箱中的另一项资产。
IF 7.8 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-12-01 Epub Date: 2024-11-08 DOI: 10.1161/CIRCHEARTFAILURE.124.012244
Stefano Toldo, Guglielmo Gallone, Antonio Abbate
{"title":"Inhibitors of the Interleukin-1 Receptor Accessory Protein Signaling: Another Asset in the Cardio-Immunology Toolbox.","authors":"Stefano Toldo, Guglielmo Gallone, Antonio Abbate","doi":"10.1161/CIRCHEARTFAILURE.124.012244","DOIUrl":"10.1161/CIRCHEARTFAILURE.124.012244","url":null,"abstract":"","PeriodicalId":10196,"journal":{"name":"Circulation: Heart Failure","volume":" ","pages":"e012244"},"PeriodicalIF":7.8,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11652230/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142603409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute Heart Failure Caused by Rupture of Sinus of Valsalva Into Right Atrium in a Patient With Possible Infective Endocarditis After Tricuspid Annuloplasty: A Misdirected Clinical Decision-Making. 一名三尖瓣瓣环成形术后可能患有感染性心内膜炎的患者因瓦尔萨尔瓦窦破裂进入右心房而导致急性心力衰竭:错误的临床决策。
IF 7.8 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-12-01 Epub Date: 2024-11-05 DOI: 10.1161/CIRCHEARTFAILURE.124.011600
Daiki Toyoshima, Yasuhide Mochizuki, Sunao Handa, Daisuke Yokokawa, Saori Chino, Rumi Hachiya, Hiroto Fukuoka, Toshiro Shinke
{"title":"Acute Heart Failure Caused by Rupture of Sinus of Valsalva Into Right Atrium in a Patient With Possible Infective Endocarditis After Tricuspid Annuloplasty: A Misdirected Clinical Decision-Making.","authors":"Daiki Toyoshima, Yasuhide Mochizuki, Sunao Handa, Daisuke Yokokawa, Saori Chino, Rumi Hachiya, Hiroto Fukuoka, Toshiro Shinke","doi":"10.1161/CIRCHEARTFAILURE.124.011600","DOIUrl":"10.1161/CIRCHEARTFAILURE.124.011600","url":null,"abstract":"","PeriodicalId":10196,"journal":{"name":"Circulation: Heart Failure","volume":" ","pages":"e011600"},"PeriodicalIF":7.8,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142575386","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Circulation: Heart Failure
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1